Cita APA (7a ed.)
Masoodi, M., Talebi-Taher, M., Tabatabaie, K., Khaleghi, S., Faghihi, A., Agah, S., & Asadi, R. (2015). Clarithromycin vs. Gemifloxacin in Quadruple Therapy Regimens for Empiric Primary Treatment of Helicobacter pylori Infection: A Randomized Clinical Trial. Middle East Journal of Digestive Diseases, 7(2), 13-19.
Cita Chicago Style (17a ed.)
Masoodi, Mohsen, Mahshid Talebi-Taher, Khadijeh Tabatabaie, Siamak Khaleghi, Amir-Hossein Faghihi, Shahram Agah, y Reyhaneh Asadi. "Clarithromycin Vs. Gemifloxacin in Quadruple Therapy Regimens for Empiric Primary Treatment of Helicobacter Pylori Infection: A Randomized Clinical Trial." Middle East Journal of Digestive Diseases 7, no. 2 (2015): 13-19.
Cita MLA (9a ed.)
Masoodi, Mohsen, et al. "Clarithromycin Vs. Gemifloxacin in Quadruple Therapy Regimens for Empiric Primary Treatment of Helicobacter Pylori Infection: A Randomized Clinical Trial." Middle East Journal of Digestive Diseases, vol. 7, no. 2, 2015, pp. 13-19.
Precaución: Estas citas no son 100% exactas.